Article info
Electronic pages
Correspondence
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use
- Correspondence to Dr Lucas L van den Hoogen, University Medical Centre Utrecht, Laboratory of Translational Immunology, KC.02.085.2, Lundlaan 6, Utrecht 3584 GA, The Netherlands; l.l.vandenhoogen{at}umcutrecht.nl
Citation
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use
Publication history
- Received September 7, 2016
- Accepted September 13, 2016
- First published September 28, 2016.
Online issue publication
November 10, 2016
Article Versions
- Previous version (28 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/